ÐÔÃüѧԺ½ðÓÉÐÁ½ÌÊÚ¿ÎÌâ×éÔÚ΢Ó×RNAÁìÓò»ñµÃ³ÁÒª×êÑнøÕ¹

°ä²¼¹¦·ò£º2015-05-27Ͷ¸å£º³Â»Ê ²¿ÃÅ£ºÐÔÃü¿ÆÑ§Ñ§Ôº ä¯ÀÀ´ÎÊý£º

20A6E960477948208FE8A13B575_8EA0ABD1_2036D.jpg?e=

½üÈÕ£¬ÐÔÃü¿ÆÑ§Ñ§Ôº½ðÓÉÐÁ¿ÎÌâ×éÔÚ¡°Î¢Ó×RNA£¨microRNA£©Ö°ÄÜ¡±×êÑÐÖлñµÃ³ÁÒªÍ»ÆÆ¡£×êÑз¢ÏÖ£ºÖÐÒ©×é·Öµ¤²Îͪͨ¹ýµ÷¿ØÌض¨microRNA£¨miR-32£©¼°ÓйػùÒò£¬ÒÖÔì·ÇÓ×ϸ°û·Î°©³É³¤£¬²ûÑïÒ©Î﹦Ч¡£ÓÉÂíÖÐÁ¼¡¢Õűù½àµÈÈËÆ¾¾ÝÓйØ×êÑÐÁ˾Ö׫дµÄÂÛÎÄ¡°Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer¡±£¬ÓÚ5ÔÂ14ÈÕÔÚÏß°ä·¢ÓÚÖ×ÁöÁìÓò2ÇøÑ§ÊõÆÚ¿¯Oncotarget£¨IF=6.67,http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=3933£©¡£½ðÓÉÐÁ½ÌÊÚ¿ÎÌâ×éµÄ×êÑÐÈËԱͨ¹ý³¢ÊÔ·¢ÏÖ£ºµ¤²Îͪͨ¹ýת¼Òò×ÓÀ´Éϵ÷miR-32£¬´Ó¶øÒÖÔì°©»ùÒòAURKAµÄ±í°×£¬×îÖÕÒÖÔì·ÇÓ×ϸ°û·Î°©µÄ²úÉú·¢Õ¹¡£¸Ã×êÑгɾÍΪ·Î°©µÄÕï¶Ï¡¢Ò½ÖÎÌṩÁ˳ÁÒªµÄƾ¾Ý¡£

½ðÓÉÐÁ½ÌÊÚ´ÓÊÂRNA×êÑг¤´ï30ÓàÄê£¬ÔøÈÎÖйú¿ÆÑ§ÔºÉϺ£ÐÔÃü¿ÆÑ§×êÑÐÔºÉúÎﻯѧÓëϸ°ûÉúÎïѧ×êÑÐËù¹ú¶È³Áµã³¢ÊÔÊÒÖ÷ÈΡ£2010Ä걻б¦GGÆ¸ÎªÌØÆ¸½ÌÊÚ£¬×齨RNA½á¹¹ÓëÖ°Äܳ¢ÊÔÊÒ£¬µÃµ½ÁËѧÌúÍѧԺµÄ´óÁ¦ÔÞÖú¡£½üÈýÄ꣬¿ÎÌâ×é³É¾ÍÏÔÖø£¬ÔÚOncotarget¡¢Tumor Biology¡¢ABBS¼°IUBMB LifeµÈÔÓÖ¾Éϰ䷢¶àƪÎÄÕ£¬2015Äê¿ÎÌâ×éµÄÿλ½ÌÔ±¾ùÒÑÓÐSCIÎÄÕ°䷢¡£

??? ½ðÓÉÐÁ½ÌÊڵĿÎÌâ×齫³ÖÐøË÷Çó·Ç±àÂëRNA£¨microRNA£¬³¤Á´·Ç±àÂëRNA£¬tRNA½µ½âƬ¶Î£©ÔÚÖ×Áö²úÉú·¢Õ¹¹ý³ÌÖеĻúÔ죬ΪÖ×ÁöµÄÒ½ÖÎÌṩԽ·¢¿ÉÐеÄÕï¶Ï¼°Ò½Öι滮£¬Í¬Ê±¿ÎÌâ×黹¹Ø×¢·Ç±àÂëRNAÔÚ¸Éϸ°û·½ÃæµÄÖ°ÄÜ¡£


¡¾ÍøÕ¾µØÍ¼¡¿